Venture funds, angel groups and growth equity
Widen one filter. If your sector genuinely has no local fund, that is a real signal, and the answer is usually a national investor plus a local angel network to fill the round.
I've spent 25 years inside Southern California's startup ecosystem as a founder, an accelerator director, and a seed investor. That combination of operating experience and network is how I find companies early and how I add value after the investment: strategic introductions to customers, co-investors, and follow-on capital, and hands-on help at every stage, from the first round through growth and exit.
I'm JC Ruffalo, a Partner at Cove Fund since 2021. I've helped back early-stage founders across Southern California since 2014.
I came to investing as a founder. I started three companies before I turned 30: an action-sports apparel brand, a digital marketing agency, and a heavy-equipment trading business. That is the operating lens I bring to the work. I've sat on the founder's side of the table, and I remember what it takes.
Before Cove, I was Managing Director of the LaunchPad accelerator at Octane OC from 2014 to 2021, working hands-on with founders. Those companies have since raised more than $2.5B and produced multiple IPOs and acquisitions. My path went from entrepreneur to accelerator director to investor, and that operator's perspective shapes how I work today.
I like getting in early with technical founders building real products in enterprise software, healthcare technology, and frontier systems, then staying close as they grow.
What connects all of it is a simple belief: the best companies are built on relationships and trust earned over time. I back founders who understand their customer better than anyone else in the room, who build cultures people want to be part of, and who keep going when the round is hard and the market is quiet. My job is to see them early, before the consensus forms, and to be the first call when something breaks.
I went to Chapman University and never left Southern California. I'm married with two daughters, and this is home. Outside the fund, I put my time into the ecosystem itself: judging pitch competitions, mentoring first-time founders, and mapping the region's capital so the next generation of builders can find it faster. Southern California produces more technical founders than it has capital to back them, and closing that gap is work I plan to keep doing for a long time.
Across 20 seed investments and 14 follow-ons, with reserves active for the strongest performers.
CalTech robotics-safety software, acquired Q2 2026 at ~1.8x and ~41% IRR.
RNA therapeutics company acquired by Novartis.
Medtech IPO from the LaunchPad community (Nasdaq: RXST), alongside Acorns and Hyperice.
3Laws Robotics came out of Caltech. I sourced the company, Cove backed it at seed, and Amazon acquired it in 2026. Quantum Elements, Occuspace, and iCardio followed the same playbook: find technical founders early, back them at seed, and stay close through follow-ons and the exit.
| Company | Sector | First Inv. | Status | Notes / Outcome |
|---|---|---|---|---|
| Content.One (Zesty.io)Content management & web platform | SaaS / MarTech | 11/2021 | Active | Note + equity · going well · steady growth |
| iCardioAI-powered cardiac imaging | HealthTech / AI | 3/2026 | Active · New | $4.5M seed led by Cedars-Sinai Technology Ventures · March 2026 · held at cost |
| 3Laws RoboticsCalTech robotics safety software | Deep Tech / AI | 9/2024 | Amazon Acquisition | Acquired by Amazon · closed Q2 2026 |
| XiloInsurance quoting & sales automation | InsurTech / SaaS | 8/2022 | Portfolio Leader | Going well · strong growth · new AI product launched · positioning for Series B |
| Carro / VYRLCollaborative commerce / dropship | eCommerce / B2B | 9/2025 | Breakout | Going well · exceptional growth over the last 18 months · Cove-led follow-on June 2026 |
| BLNGJewelry intelligence platform · B2B SaaS | eCommerce / AI | 2/2025 | Breakout Quarter | Going well · enterprise wins in luxury retail · Seed II co-led by Cove |
| Quantum ElementsQuantum digital twin software | Deep Tech / Quantum | 3/2026 | Technical + Commercial Breakout | Going well · quantum digital twin work with AWS · peer-reviewed publication · oversubscribed seed extension |
| SigmaSightLitigation intelligence · B2B SaaS | LegalTech / AI | 12/2024 | Strong Traction | Going well · growth · Series A prep |
| OccuspaceSpace utilization analytics | PropTech / AI | 8/2023 | Portfolio Leader | Going well · strong growth · federal contract vehicle secured · deployments expanding · follow-on July 2026 |
| VisaicImmersive fan experience platform | Media / Sports Tech | 5/2024 | Strong Growth | Going well · strong growth · new customers and early renewals |
| VECKTAEnergy transition marketplace | ClimateTech / Marketplace | 6/2022 | Series A Signed | Series A signed, pending close · Cove follow-on August 2026 |
| Eira BioOncology & women's health therapeutics | BioTech / Oncology | 11/2025 | Solid Execution | Lead program on track · second program advancing · on budget |
| MelioCulture-free blood pathogen detection | MedTech / Diagnostics | 5/2024 | Active | CARB-X grant awarded · culture-free pathogen detection |
| Time MachineAI onboarding & training for sales teams | AI / B2B SaaS | 9/2025 | Active | Going well · growth · Series A prep |
| CelitechWhite-label eSIM for travel operators | TelecomTech / B2B2C | 6/2022 | Active | Cove-led seed · Series A prep |
| CenfireFabless semiconductor · MEMS relay tech | Semiconductors / Deep Tech | 1/2026 | Seed-2 | Silicon MEMS relay tech · Seed-2 closed · initial market T&M/ATE |
| Wethos AIDecision intelligence for teams | AI / Decision Intelligence | 7/2024 | Series A in market | Raising Series A · strong customer traction |
| ExokeryxExtracellular vesicle extraction | BioTech / Diagnostics | 9/2024 | Monitoring | First product revenue · commercial ramp is the near-term focus |
| CARI HealthReal-time medication monitoring | HealthTech | 7/2022 | Active | Real-time medication monitoring · growing clinical footprint |
LaunchPad was hands-on work: office hours, pitch prep, investor introductions, and the hard conversations before a raise. I screened more than 10,000 companies and advised more than 500 through the program. The alumni have since raised more than $2.5B and produced multiple IPOs and acquisitions.
| Company | Val. at LaunchPad | Latest Post-Money | Val. Growth | Outcome | Notes |
|---|---|---|---|---|---|
| DTx PharmaRNA therapeutics · San Diego | $6M | $1.10B (Novartis acq.) | 183x | Acquired · Novartis | Acquired by Novartis in 2023; RNA therapeutics for neuromuscular disease |
| HypericeRecovery tech · Irvine, CA | $8M | $850M (Series B) | 106x | Active · Series B | Recovery technology; Series B at an $850M valuation |
| AcornsConsumer fintech · Irvine | $19.5M (Series B, Mar 2014) | $1.8B (Series F, 2022) | 92x | Active · Series F | Consumer fintech; latest round at $870M post-money |
| NovaSignal (Neural Analytics)Brain health diagnostics · Los Angeles | $7.7M | $93M (last priced round) | 12.1x | Acquired · NeuraSignal, 2023 | Robotic brain-health diagnostics; acquired by NeuraSignal in 2023 |
| BontiBotulinum toxin biotech | $22.3M | $195M | 8.8x | Acquired · Allergan | Botulinum toxin biotech; acquired by Allergan |
| RxSightAdjustable intraocular lenses · Aliso Viejo, CA | $266M | $2.2B (2024 offering) | 8.3x | IPO · Nasdaq: RXST | Light-adjustable intraocular lens; Nasdaq IPO in 2021 |
| SentryCardPayment security fintech | $12M | $60M (Series D, 2021) | 5.0x | Active | Biometric payment card; active |
| NGD SystemsStorage semiconductor · Irvine | $22.6M | $104M (2019) | 4.6x | Active | Computational storage semiconductors; active |
| LensGenOphthalmology devices · Irvine | $19.2M | $76.2M | 4.0x | Active | Accommodating intraocular lens in development; active |
| MavenlinkPSA software | $61.4M | $235M | 3.8x | Merged · Kantata | Professional services software; merged with Kimble to form Kantata in 2022 |
I've spent 25 years in SoCal's innovation economy and built an extensive network of founders, investors, operators, and institutions. This is our ecosystem, mapped so founders can use it.
A public, filterable directory of every fund, angel network, accelerator, and program writing checks between Santa Barbara and San Diego. Use it whether you are raising your first round or looking for the right program.
At Cove Fund, that network extends to our investors. Our LPs are entrepreneurs, physicians, C-suite executives, fund managers, and service providers across a wide range of industries, and they are actively engaged in seeing deals alongside us and advising the companies we back. We call this relationship capital, and it is our strategic value to the entrepreneur.
A collaborative community of LPs across industries. They get deeply engaged, looking at deals with us and advising the companies together.
VCs, family offices, and strategics built over seven years running Octane's flagship accelerator and five years at Cove.
Members join monthly screenings, ask the hard questions, dig into the companies, and sit on diligence panels. After the check, they open doors to customers, key hires, co-investors, and strategic partners.
"Very encouraging journey for your leadership in OC's VC ecosystem."
Doug Holte, Cove Fund I investor and former President, Irvine Company
"QUOTE FROM A COVE III FOUNDER"
Name, CEO, Company
"QUOTE FROM A LAUNCHPAD ALUM OR CO-INVESTOR"
Name, Title, Company
Deal flow is driven by a network spanning key innovation hubs, built through years operating at the center of founder, university, and investor ecosystems. Rooted in Southern California but national in reach, surfacing high-potential companies before they become broadly visible. Cove Fund III reviewed 4,762 companies over the life of the fund, six times the volume of Fund II, and funded 20 of them, about 0.4% of the pipeline.
At the seed stage, outcomes are driven by a small number of breakout companies. The strategy identifies these early, supported by a decade of pattern recognition and data-backed selection, then concentrates time, conviction, and follow-on capital behind the strongest positions.
We partner closely with founders through the most critical stages of company formation and early growth — strategic positioning and narrative, customer and investor introductions, and navigating the Seed → Series A transition.
A working directory of the funds, angel networks, accelerators and programs that actually write checks in Southern California.
Widen one filter. If your sector genuinely has no local fund, that is a real signal, and the answer is usually a national investor plus a local angel network to fill the round.
A Santa Monica seed fund writing $600K checks beats a Newport Beach growth firm ten minutes away. Sort by stage, then by drive time.
Cold forms are worth close to nothing. Get to twenty names, then work backwards through customers, advisors, and existing investors for a warm route into each.
Several firms say plainly what they won't do. Read that and take yourself off the list. A fast no beats a slow maybe.
Almost nobody funds a first meeting. Start the relationship the quarter before you need it and let them watch you hit your numbers.
The people who can open a door for you are the most valuable asset in a raise. I can help connect you to some of the firms here, not all. Use Request intro, tell me why the fund is a fit, and I'll do what I can.
Strategies change between vintages and accelerator terms change every cohort. This reflects public statements as of September 2026. Confirm before you build a decision on it.
Tell me about the company and why this fund is a fit. I read every request and make the intros I can stand behind.
Thanks. If it's a fit, I'll reach out to the fund and copy you.
No problem. Your request is copied below. Email it to INTRO_ADDR or open it in your mail app.